Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas
Authors:
Open Access
- 11 July 2022
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 18 (24) , 2639-2649
Abstract
Poorly differentiated neuroendocrine carcinomas such as small-cell lung cancer (SCLC) have poor survival and high relapse rates. DLL3 is found on these carcinomas and has become a target of increas... Plain language summary DLL3 is a protein involved in development of the embryo during pregnancy. It has also been found on the surface of cells involved in the development of certain types of lung ...Keywords
Funding Information
- Boehringer Ingelheim
This publication has 20 references indexed in Scilit:
- DLL3: an emerging target in small cell lung cancerJournal of Hematology & Oncology, 2019
- Immune checkpoint inhibitors for small cell lung cancer: opportunities and challengesOncoTargets and Therapy, 2019
- Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancerScience Translational Medicine, 2019
- Prognosis of patients with neuroendocrine tumor: a SEER database analysisCancer Management and Research, 2018
- Prevalence of Delta-like protein 3 expression in patients with small cell lung cancerLung Cancer, 2018
- Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 studyThe Lancet Oncology, 2017
- Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?Journal of Thoracic Oncology, 2016
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivoScience Translational Medicine, 2015
- Critical aspects of the Bayesian approach to phase I cancer trialsStatistics in Medicine, 2008
- Cancer phase I clinical trials: efficient dose escalation with overdose controlStatistics in Medicine, 1998